NM/CT 860

The ideal balance of CT performance and clinical capability

NM/CT 860 is a SPECT/CT system designed for high-performance clinical environments. It combines the SPECT and productivity enhancements of the 800 Series with an optimal balance of CT technology. Technology with the thin-slice CT performance you need for all of your SPECT/CT protocols and the most common standalone CT exams, without overlapping with your other CT assets. NM/CT 860 is exactly what you need to continue to grow and strengthen the clinical value of nuclear medicine by making it more accessible in routine care.
TECHNOLOGY

Optimized for everyday imaging

All our new 800 Series SPECT/CT systems build on the success of the 600 Series with a collection of SPECT technology enhancements that add to the value of nuclear medicine. In addition to the all-new SmartConsole, these enhancements include a new LEHRS (Low Energy High Resolution and Sensitivity) collimator, which can be combined with either SPECT Step & Shoot Continuous scanning mode or our Planar Clarity 2D processing to increase sensitivity and enable a reduction of scan times or injected dose1. It’s called SwiftScan Planar and SwiftScan SPECT. NM/CT 860 also includes the Elite NXT detectors, designed to address some of nuclear medicine’s biggest challenges.

We paired these great SPECT enhancements with our Revolution™ ACTs CT system. It’s an eight-slice CT system with fine resolution and contrast, as well as IQ Enhance, a reconstruction technology that makes it possible to scan at a faster helical pitch to cover more anatomy at similar image quality. This combination of imaging technologies allows you to provide both advanced SPECT/CT exams and the most common overflow standalone CT exams.
All without adding duplicate capabilities to your asset mix.

  • I  Shorter photomultiplier tubes combined with lean front-end electronics reduce analog noise and improve performance
  • I  Collimators optimized for high sensitivity, low septal penetration and high resolution
  • I  Exceptional NEMA resolution for SPECT in a detector box that is 13 cm slimmer
  • I  Evolution technology for up to a 50 percent reduction of scan time or patient dose2
  • I  Enable a reduction of dose or scan times by up to 25 percent with the increased sensitivity of SwiftScan Planar and SwiftScan SPECT1
  • I  Improved small lesion detectability with SwiftScan Planar and SwiftScan SPECT3
  • I  ASiR™ technology can help you achieve your low-dose CT needs4
PRODUCTIVITY

Switch to an all-digital workflow with SmartConsole

Introducing SmartConsole. It’s an all-new productivity hub for hybrid imaging. By automating SPECT/CT reconstruction, SmartConsole simplifies the workflow for complex hybrid and quantitative protocols and allows technologists to review results directly at the scanner console. It also allows physicians to review scans remotely from their own mobile devices. They can modify processing settings and initiate study processing anytime, anywhere across a LAN or a WAN*. That means better collaboration during scans and better accessibility for reviewing scans once complete.

SmartConsole enables a noticeable improvement in productivity. Now, a physician can provide their input remotely and digitally. For example, physicians can review a whole-body bone scan directly on their tablet or other mobile device and define the scan range limits that they need from wherever they are. The time saved with this switch to a digital workflow helps make it possible to complete exams in predictable time slots.

*Minimum hardware and software requirements apply.

  • Save time and steps by remotely collaborating with a clinician mid-exam
  • Enhance productivity with simplified workflows for complex procedures
  • Easy-to-use user interface helps your department operate efficiently

One home for all of your molecular images

SmartConsole makes advanced procedures more accessible by transferring exams directly to the PACS or other pre-defined DICOM destinations with no operator intervention. Now, you can generate and send an additional dataset in PET DICOM format to enable quantitative SPECT results and SPECT SUV (Standard Uptake Value) on any PET DICOM compliant workstation or PACS. As a result, referring physicians can review and evaluate your SPECT/CT exams with the same quality of information they have come to expect from your PET/CT, as supplemental information to the original SPECT/CT images. All of which is part of our ongoing vision to grow and strengthen the role of nuclear medicine.

  • Improve workflow with automated transfer and archive features
  • Streamline access to SPECT/CT and quantitative SPECT/CT studies
  • Optimize image quality post-exam with retrospective processing features
CAPABILITY

The right mix of SPECT and CT capability

Until now, many advanced hybrid and quantitative protocols have been limited to research institutions with the extra resources needed to provide complex protocols. Through SmartConsole and Xeleris™, NM/CT 860 makes these protocols available in routine settings by reducing the resources needed to perform them.

A simpler way to bring everything together




Q.Volumetrix MI is an Xeleris 4 DR application that integrates SUV measurements directly into the volume viewer. It allows you to see both the image and the SUV simultaneously instead of having to switch back and forth between two separate applications.
Then, with SmartConsole, your quantitative SPECT/CT studies are automatically transferred directly to the PACS or other pre-defined DICOM destination. These resource-saving improvements allow you to expand your services without breaking your schedule.

Stay on top of the latest trends in imaging




Grow your referral volume by offering therapy and surgical planning procedures.

A CT that stands out when it stands alone




Revolution ACTs gives you the thin-slice performance you need for all of your SPECT/CT exams and standalone CT capability for the most common overflow CT studies. Not only that, but you get the added time savings of being able to acquire a diagnostic CT exam at the same time as a SPECT/CT exam, which helps improve the patient experience. In addition, Revolution ACTs has the dose reduction technology referring physicians expect with every exam.

FUTURE-READY

A system that’s ready for the future when you are

NM/CT 860 shares the same modular design as the rest of the 800 Series family of nuclear medicine systems. They all share a common user interface and collimators, which makes it easier both operationally and financially to upgrade to another 800 Series system or to add another system to your overall asset mix. Its modular design also means you have the option to purchase SPECT advancements like SwiftScan Planar and SwiftScan SPECT now, or in the future.

  • Cost-effective access to future innovation
  • Access future image quality enhancements and Cloud Analytics with the future-ready SmartConsole
  • Reduce cost and save space by sharing collimators with existing 600 Series and 800 Series systems
QUANTITATIVE APPLICATIONS

Inform your decisions with measurable results

The Xeleris workstation is our Nuclear Medicine, PET, NM/CT and PET/CT processing, analysis and review system. It’s designed to leverage the latest in SPECT quantitative applications for routine clinical use, accelerate workflow and improve diagnostic confidence. It also opens the door to the new era of digital healthcare delivery through its potential to access the GE Health Cloud and with advanced applications to help solve some of the most complex clinical presentations.

SUMMARY

A SPECT/CT system for true discovery

Molecular imaging is unlike any other imaging technology because it enables the search for true discovery. It’s the type of discovery that reveals a new way to understand something hidden deep within us. It’s what inspires confidence in the accuracy of what you see and in your ability to find disease sooner. It’s this diagnostic confidence that strengthens the value of nuclear medicine throughout the healthcare community.

Continuing to grow the clinical value of SPECT/CT technology takes as much of a commitment from the people who use it as it does from the people who make it. You, like us, are committed to making true discovery even more accessible to the patients you serve. It’s why we partnered with you to better understand what your financial and operational challenges might be. It’s also why we created NM/CT 860 to help you overcome those challenges, so you can continue to pursue true discovery.

  • 1 Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/dose for the particular clinical task.
  • 2 In clinical practice, Evolution options2a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit2b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
  • 2a Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.
  • 2b Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by   showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the   images reconstructed with FBP / OSEM.
  • 3 As demonstrated in phantom testing using a model observer. For SPECT, compared to using the LEHR Collimator and a SPECT Step & Shoot acquisition. For Planar, compared to using LEHR without Clarity 2D.
  • 4 In clinical practice, the use of ASiR or VISR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.